Regent Investment Management’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $8.01M | Sell |
85,936
-1,149
| -1% | -$111K | 2.15% | 7 |
|
|
2022
Q3 | $8.3M | Sell |
87,085
-608
| -0.7% | -$60.2K | 2.42% | 7 |
|
|
2022
Q2 | $8.13M | Buy |
87,693
+96
| +0.1% | +$9.37K | 2.27% | 8 |
|
|
2022
Q1 | $8.87M | Sell |
87,597
-1,097
| -1% | -$115K | 2.05% | 11 |
|
|
2021
Q4 | $9.15M | Buy |
88,694
+612
| +0.7% | +$56.6K | 1.99% | 10 |
|
|
2021
Q3 | $7.47M | Sell |
88,082
-79
| -0.1% | -$6.62K | 1.79% | 11 |
|
|
2021
Q2 | $7.36M | Buy |
88,161
+874
| +1% | +$71.6K | 1.72% | 11 |
|
|
2021
Q1 | $6.57M | Buy |
87,287
+15,904
| +22% | +$1.16M | 1.65% | 12 |
|
|
2020
Q4 | $4.88M | Sell |
71,383
-2,620
| -4% | -$170K | 1.35% | 14 |
|
|
2020
Q3 | $4.32M | Sell |
74,003
-893
| -1% | -$55.6K | 1.34% | 17 |
|
|
2020
Q2 | $4.87M | Buy |
74,896
+262
| +0.4% | +$16.5K | 1.62% | 13 |
|
|
2020
Q1 | $4.43M | Buy |
74,634
+3,842
| +5% | +$256K | 1.82% | 15 |
|
|
2019
Q4 | $5.26M | Sell |
70,792
-5,612
| -7% | -$394K | 1.61% | 11 |
|
|
2019
Q3 | $4.82M | Buy |
76,404
+6,475
| +9% | +$384K | 1.58% | 12 |
|
|
2019
Q2 | $3.81M | Sell |
69,929
-1,900
| -3% | -$102K | 1.24% | 20 |
|
|
2019
Q1 | $3.87M | Buy |
71,829
+1,055
| +1% | +$65.1K | 1.29% | 19 |
|
|
2018
Q4 | $4.64M | Buy |
70,774
+4,451
| +7% | +$332K | 1.74% | 12 |
|
|
2018
Q3 | $5.22M | Sell |
66,323
-1,140
| -2% | -$81.5K | 1.64% | 11 |
|
|
2018
Q2 | $4.34M | Sell |
67,463
-1,476
| -2% | -$97.3K | 1.45% | 16 |
|
|
2018
Q1 | $4.29M | Buy |
68,939
+1,575
| +2% | +$113K | 1.45% | 16 |
|
|
2017
Q4 | $4.88M | Buy |
67,364
+1,470
| +2% | +$107K | 1.6% | 13 |
|
|
2017
Q3 | $5.36M | Sell |
65,894
-600
| -0.9% | -$47.5K | 1.8% | 11 |
|
|
2017
Q2 | $5.35M | Sell |
66,494
-324
| -0.5% | -$25.6K | 1.88% | 12 |
|
|
2017
Q1 | $5.25M | Buy |
66,818
+429
| +0.6% | +$34.2K | 1.98% | 10 |
|
|
2016
Q4 | $5.24M | Sell |
66,389
-2,742
| -4% | -$222K | 2.68% | 5 |
|
|
2016
Q3 | $6.15M | Sell |
69,131
-425
| -0.6% | -$40.1K | 3.2% | 2 |
|
|
2016
Q2 | $6.66M | Sell |
69,556
-790
| -1% | -$78.7K | 3.62% | 1 |
|
|
2016
Q1 | $7.3M | Buy |
70,346
+23
| +0% | +$2.24K | 4.06% | 1 |
|
|
2015
Q4 | $6.88M | Sell |
70,323
-850
| -1% | -$83.2K | 3.67% | 1 |
|
|
2015
Q3 | $6.87M | Buy |
71,173
+2,070
| +3% | +$218K | 3.78% | 1 |
|
|
2015
Q2 | $7.25M | Buy |
69,103
+265
| +0.4% | +$27.1K | 3.65% | 1 |
|
|
2015
Q1 | $7.11M | Sell |
68,838
-795
| -1% | -$80.4K | 3.6% | 1 |
|
|
2014
Q4 | $6.71M | Sell |
69,633
-2,490
| -3% | -$219K | 3.44% | 1 |
|
|
2014
Q3 | $5.74M | Sell |
72,123
-338
| -0.5% | -$26.6K | 2.94% | 2 |
|
|
2014
Q2 | $5.46M | Buy |
72,461
+1,235
| +2% | +$93.3K | 2.69% | 2 |
|
|
2014
Q1 | $5.33M | Buy |
71,226
+6,310
| +10% | +$446K | 2.82% | 1 |
|
|
2013
Q4 | $4.65M | Buy |
64,916
+4,275
| +7% | +$275K | 2.61% | 2 |
|
|
2013
Q3 | $3.44M | Buy |
60,641
+2,310
| +4% | +$138K | 2.27% | 5 |
|
|
2013
Q2 | $3.33M | Buy |
+58,331
| New | +$3.38M | 2.57% | 3 |
|
Other funds holding CVS
AWA
Regent Investment Management's CVS Position: Q4 2022 in Review
Regent Investment Management reduced its CVS Health (CVS) stake by 1.3% in Q4 2022, selling an estimated $111K and leaving 85,936 shares worth $8.01M. The position accounts for 2.15% of the portfolio, ranked #7.
Regent Investment Management first reported a position in CVS in Q2 2013 and has held it in 39 quarters since. The position peaked at $9.15M in Q4 2021. 2,405 funds tracked by Wall St. Rank hold CVS as of Q4 2022.
- Regent Investment Management held 85,936 shares of CVS Health worth $8.01M as of Q4 2022.
- Regent Investment Management sold 1,149 CVS Health shares in Q4 2022, an estimated $111K.
- CVS Health made up 2.15% of Regent Investment Management's portfolio in Q4 2022, its #7 holding.
- Regent Investment Management first reported a position in CVS Health in Q2 2013 and has held it in 39 quarters since.
- Regent Investment Management's CVS Health position peaked at $9.15M in Q4 2021.
- 2,405 funds tracked by Wall St. Rank held CVS Health as of Q4 2022.
Based on Regent Investment Management's 13F filing for Q4 2022, filed 26 Jan 2023.